Orin
TERNasdaq·Semiconductors

Teradyne, Inc. TER

Market cap $59.6BP/E 53.1× trailingGross margin 59.3%Reports Tue 27 Oct, after the close
$381.50
−7.64 (−1.96%)live 09:30 ET
52-wk $128.59 – $487.91
Watch
Orin's take
0.62conviction · moderate
Refreshed 18 Aug · take v7. A new filing or a print queues the next refresh.

Teradyne's AI-driven semiconductor test recovery is genuine—FY2025 revenue grew 13.1% to $3.19B and smart money fund count rose from 58 to 67 as of the quarter ended 2026-06-30—but the stock's run to $443 (46% above its 200-day MA of $303) has left valuations stretched at 15.5x sales, 155% above the peer median. Insider selling by the CEO (4,000 shares at $356.31 on 2026-07-15) and net insider disposition value of $13.1M over 24 months, combined with FY2025 EPS growth of just 4.8% lagging revenue growth of 13.1%, signal the easy money has been made.

Hold pending evidence that earnings momentum can justify the premium multiple.

What could go wrong

  • Valuation compression. P/S of 15.5x is 155% above peer median of 6.08x; EV/EBITDA of 47.5x is 111% above peer median of 22.5x, leaving the stock vulnerable to any disappointment in growth.
  • Insider selling. CEO Gregory Smith sold 4,000 shares at $356.31 on 2026-07-15; 24-month net insider transaction value is -$13.1M across 97 transactions.
  • Margin pressure. Net margin declined from 19.23% in FY2024 to 17.37% in FY2025 despite 13.1% revenue growth, indicating operating leverage is not fully flowing through.
  • Technical overextension. RSI at 64.7 and stock trading 46% above its 200-day MA of $303.32 as of 2026-08-17 increases pullback risk after a rapid advance.

What would change my mind

Q3 2026 earnings. Revenue and EPS beat consensus with raised guidance, confirming the AI-test acceleration is sustainingbullish
Operating margin expansion. Quarterly operating margin exceeds the FY2025 level of 21.74%, showing improving leverage on higher revenuebullish
Insider buying reversal. Open-market insider purchases exceed dispositions over a trailing 90-day windowbullish
Multiple compression. P/S fails to contract toward the peer median of 6.08x on slowing revenue growth or guide-downbearish

Where this comes from: FMP annual fundamentals + derived_metrics, FY2025 · peer_relative composite, as of 2026-08-17 · insider transactions, SEC Form 4 filings · insider summary, 24-month window. Orin's read on TER; not advice.

Twelve months actual closes to 2026-09-23 · actual filings

Sept 25Nov 25Jan 26Mar 26May 26Jul 26

50-day average 200-day average · volume below

Largest holders · 13F Q2 2026

Money flow
FilerPositionOf fund
Vanguard Capital Management$4.9B0.1% of fund
Vanguard Portfolio Management$4.2B0.2% of fund
State Street$3.5B0.1% of fund
Invesco$3.2B0.3% of fund
Jpmorgan Chase &$2.6B0.1% of fund
Geode Capital Management$2.2B0.1% of fund

122 filers · quarter ended Q2 2026 · positions, not flows

Insiders, last 24 months: 103 Form 4 filings, net −$17.2M. Of the 50 on hand, 0 were open-market purchases and 23 sales— the rest are grants, option exercises and tax withholding.

Ask Orin about TER

its filings · its transcripts · its numbers

Orin answers questions about TER from its filings, transcripts and numbers — with the source behind every claim. Your own desk starts with 3 free days, card required.

Start 3 free days

Where it trades

vs its own 5y · Technology
MetricNowOwn medianSector
P/E53.1×36.9×53.3×
EV/EBITDA41.7×25.2×
P/S13.63×7.10×
P/B17.7×7.1×

Its P/E sits 80th percentile of its own last 5 years (+1.52σ from its own mean).

What the price assumes

34.2%

free-cash-flow growth every year for 10 years, discounted at 10%, is what today’s price implies — starting from $0.5B of trailing free cash flow. It is an assumption the market is making, not a forecast Orin is making.

What Wall Street published

31 firms · 2026-09-23
Consensus target

$462

$390$550 · +21% against today's price

How they rate it
  • 19 buy or overweight
  • 12 hold
  • 0 underweight or sell

The analysts’ consensus and their own ratings, not Orin’s. A target is a twelve-month opinion published by the firm that wrote it.

Against the companies it is compared to

median P/E 48.7× of 9 peers
CompanyMarket capP/EEV/EBITDAGrossNetROE
TERTeradyne, Inc.$61B53.1×41.7×59.3%25.8%38%
ALABAstera Labs, Inc. Common Stock$62B166.1×184.7×75.1%30.7%25%
ASXASE Technology Holding Co., Ltd.$97B49.8×21.1×19.5%8.5%17%
KEYSKeysight Technologies, Inc.$60B48.7×35.3×64.7%19.1%20%
MCHPMicrochip Technology Incorporated$41B104.7×27.4×60.2%8.8%7%
ONON Semiconductor Corporation$29B46.9×23.6×37.4%10.2%8%
SMCISuper Micro Computer, Inc.$27B11.4×8.5×10.8%5.7%25%
SNDKSandisk Corporation$269B23.4×20.2×71.5%56.5%93%
STMSTMicroelectronics N.V.$47B99.8×20.8×34.3%3.5%3%
UMCUnited Microelectronics Corporation$62B23.9×12.5×30.6%33.3%21%

The median is of the 9 peers listed above and nothing else — check it against the column. This company trades 9.1% above it. The peer set is the vendor’s, so a company can appear here that a person would not have chosen.

What it has traded at

P/E by fiscal year
FY14 49.5×FY25 55.5×

What its sector has traded at

Technology
FY14 9.0×FY26 48.0×

Two scales, drawn separately on purpose: a sector median and one company’s multiple are not the same number and putting them on one axis invites a comparison neither series supports.

Discounted cash flow

not recomputed since
ModelFair valueAgainstComputed
Standard DCF$47$349.75 · −87%2026-06-10
Levered DCF$51$349.75 · −85%2026-06-10

The vendor’s intrinsic-value models. Treat them as a low-growth anchor — for a fast grower the market routinely pays well above a DCF. These were computed against the price in the “against” column, not today’s.

Every estimate on one scale

price $381.50
52-week range$129 – $488
Analyst targets$390 – $550
Standard DCF$47 as of 2026-06-10, when it was $349.75
Levered DCF$51 as of 2026-06-10, when it was $349.75
At own 5y-median P/E (37×)$271
At 5y P/E range (19–55×)$142 – $401
At sector P/E (53×)$391

The vertical rule is the current price. Ranges and point estimates are the backend’s, published as they were calculated; an arrow means the estimate sits beyond this scale, and its number is on the right.